Nublexa 40 mg Tablet contains Regorafenib, a potent kinase inhibitor that actively treats several types of cancer, including metastatic colorectal cancer, hepatocellular carcinoma (liver cancer), and gastrointestinal stromal tumors (GISTs). By blocking abnormal proteins that promote cancer cell growth, Nublexa slows or stops tumor progression. For more detailed cancer information, visit Mayo Clinic, Drugs.com, and FDA.

Key Benefits & Uses

Nublexa 40 mg delivers several benefits for cancer patients:

• Colorectal Cancer: Doctors prescribe it to patients with metastatic colorectal cancer who have already undergone standard chemotherapy. Learn more at WebMD.

• Hepatocellular Carcinoma: It treats liver cancer in patients whose disease progressed after sorafenib therapy (PubMed).

• Gastrointestinal Stromal Tumors: Physicians recommend Nublexa for patients who failed prior treatments with imatinib or sunitinib (Healthline).

Moreover, you can access global cancer guidance at the World Health Organization.

How to Use

Take Nublexa 40 mg Tablet once daily during the first 21 days of each 28-day cycle, followed by a 7-day rest period. Swallow the tablet whole with a glass of water after a low-fat meal (under 600 calories and less than 30% fat). Do not crush or break the tablet. For complete instructions, visit Drugs.com or Mayo Clinic.

Important Safety

Regularly monitor liver enzymes and stop treatment if significant liver damage occurs. Avoid Nublexa during pregnancy or breastfeeding due to potential harm to the fetus or infant. Additionally, avoid grapefruit and certain medications like St. John’s wort because they may interact with Nublexa. For detailed safety guidelines, consult FDA and WebMD.

Common Side Effects

Patients may experience fatigue, diarrhea, hand-foot skin reactions, hypertension, or loss of appetite. If you notice severe side effects, contact your healthcare provider immediately. For more information, see Healthline and Mayo Clinic.

Why Choose Nublexa

Doctors prescribe Nublexa 40 mg as a targeted therapy with proven effectiveness in multiple cancer types. It delivers significant benefits while minimizing risks under strict medical supervision. For evidence-based research, visit PubMed or the WHO for global health guidance.